NOF (4403) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Feb, 2026Executive summary
Net sales for the nine months ended December 31, 2025, rose 1.3% year-over-year to ¥173,472 million, but operating profit fell 11.0% to ¥31,826 million and profit attributable to owners of parent declined 7.5% to ¥25,565 million.
The business environment was impacted by global economic uncertainty, high raw material and fuel prices, and geopolitical risks, though domestic personal consumption in Japan showed gradual recovery.
Management focused on expanding business, developing new products, improving productivity, and cost reduction under the 2025 Mid-Term Management Plan.
Financial highlights
Gross profit decreased to ¥62,208 million from ¥64,690 million year-over-year.
Comprehensive income increased 16.4% year-over-year to ¥30,567 million.
Basic earnings per share for the period was ¥110.81, down from ¥116.14 year-over-year.
Equity-to-asset ratio was 75.3% as of December 31, 2025.
Outlook and guidance
Full-year net sales forecast revised to ¥260,500 million (up 9.3% year-over-year), with operating profit of ¥46,000 million (up 1.5%) and profit attributable to owners of parent of ¥39,400 million (up 8.0%).
Year-end dividend forecast raised to ¥35.00 per share, total annual dividend projected at ¥61.00 per share.
Latest events from NOF
- Profits fell but full-year outlook and shareholder returns were raised on segment growth.4403
Q2 202618 Nov 2025 - Net sales rose slightly, but profits declined amid global uncertainty and higher costs.4403
Q1 20266 Aug 2025 - Sales and profits climbed in H1 FY2024, with guidance and shareholder returns both increased.4403
Q2 202513 Jun 2025 - Strong Q1 profit growth driven by Functional Chemicals; full-year outlook maintained.4403
Q1 202513 Jun 2025 - Record profits, higher dividends, and robust capital returns drive future growth.4403
Q4 20256 Jun 2025 - Sales and profits rose, driven by Functional Chemicals, with stable outlook and shareholder returns.4403
Q3 20255 Jun 2025